Connect with us

Insight

Danish startup’s tech-enabled jewellery to tackle sexual harassment

Published

on

With jewellery that doubles as a discreet safety device, Danish startup All U Me is combining social impact with innovation to address the significant impact of sexual harassment on women’s health and wellbeing.

One in three women has experienced physical or sexual violence, and around half have experienced sexual harassment since the age of 15. The misconception that these incidents always occur late at night and in dark alleyways overlooks the reality of these experiences, which for many women are a part of everyday life.

The Government Equalities Office reports that almost 72 per cent of the UK population has experienced sexual harassment at work in their lifetime. Research shows that 56 per cent of women have experienced harassment in gyms, while 60 per cent of women had been harassed while running, and 11 per cent stopped running altogether as a result.

“It’s the everyday experiences that are the problem,” Dorte Caroline Knudsen (pictured above), founder of Danish startup All U Me tells Femtech World. 

“It’s not just walking down a dark street in the middle of the night, it’s the everyday, in the supermarket, on the bus, where you experience feeling unsafe or your boundaries not being respected. It’s the mental load that women are expected to carry, almost without talking about it, to get home safely. I can get home safe; I’m not the problem.”

After 14 years as head of products at a Danish software company, at the age of 47, Knudsen felt called to channel her skills into more purposeful entrepreneurship. Inspired by the UN’s Sustainable Development Goals and anger at the global prevalence of gender-based violence, she began looking into what solutions were currently being developed to address it.

“It was sad to see that none of the solutions said anything about prevention,” she says. “All the focus was on normalising what is going on and putting the responsibility on women.”

In response, Knudsen has created a solution that aims to empower women, while also shifting “safety” from an individual to a collective responsibility. 

“The beauty of feeling free”

All U Me has designed a range of jewellery featuring delicate gold and silver chains and ocean-inspired charms, which double up as an alarm system to enable them to call for help when they feel unsafe. 

“Tech is wonderful, but it can do more when it’s put into something beautiful, which is very rarely seen in the tech space,” says Knusden.

“Most of the existing solutions were one-size-fits-all, but women don’t work like that. We want to wear something that makes us feel beautiful.”

As well as being beautiful to look at, the jewellery is practical. Fully waterproof and with a battery life lasting up to four years, it is designed to be worn all the time, making it “probably the first real wearable”, according to Knusden. 

Each item has a discreet button, linked via Bluetooth and GPS to an app connecting the wearer to nearby bystanders. This may be friends or family who have downloaded the app to their phone specifically for this purpose, or other All U Me users in the local area. 

If a woman finds herself in an uncomfortable or unsafe situation, three firm pushes of the button notify up to 20 nearby bystanders or ‘backups’ with her location, alerting them to the incident so that they can intervene. 

The app trains all users in the 5D bystander intervention method – distract, delegate, delay, direct, document – in as little as three minutes, so they can choose the approach that feels right at the time. 

This is designed to break down some of the barriers that may prevent people from stepping in, such as not noticing, not being sure whether help is wanted, or not knowing what to do, Knudsen explains. 

“The feedback we get from the workshops we do is that people like to have a framework. Empowering bystanders, by telling them ‘this is what you need to do’, and ‘this is when you need to do it’, makes people a little bit more inclined to help,” she says.

“It’s no more genius than the technology that already exists, and there are times when it might not work, but that’s why the feeling of security is so important, because that’s the everyday benefit of this.”

According to All.u.me’s focus groups, 98.8 per cent of people being trained in these methods feel there’s at least one thing they can do the next time they witness harassment, while 76 per cent who saw harassment after attending the training reported that they intervened.

“The jewellery is just one element,” Knudsen continues.

“It’s actually much more about the feeling of safety and belonging to a community that I hear our users appreciate every day, and the dialogue around it. Maybe it’s telling your loved ones why you want this jewellery, or maybe it’s somebody on the bus, or the bus driver, the bartender, or the guy at the fitness center who has the app. It’s not a guarantee, but that’s where the social responsibility kicks in, and of course, our most important job is to make sure that people have the app.”

Reframing femtech

Safety and sexual harassment can be overlooked in the femtech sector. Both the World Health Organization and the US Centers for Disease Control classify sexual violence as a major public-health issue, and evidence shows that these experiences can not only have a significant impact on mental health but can also lead to physical symptoms and an increased risk of developing chronic conditions, contributing to long-term health disparities.

One recent study found that women who had experienced being stalked and/or obtained a restraining order had a 41 per cent and 70 per cent higher risk of developing cardiovascular disease, respectively. Other research has shown that women with a history of violence are around twice as likely to develop chronic pain conditons and are over-represented among women with conditions such as chronic pelvic pain, IBS, and migraine

In many ways, All U Me expands the understanding of femtech, centering safety as a foundation for health and equality. But Knusden is wary of being labelled as a ‘femtech’ company.

“The fact that safety is not seen as femtech is quite weird, actually, when statistically so many of us will experience harassment,” she says.

“But I also want to acknowledge that there are so many people who can benefit from this. It’s not just about gender equality, it’s for anybody who may feel unsafe in society.”

Not a jewellery brand, but a tech enabler 

The more people who have the app, the more effective the tool is. While women can create their own networks from anywhere by asking friends and family to download the app, it works most effectively in more populated urban areas where more users are likely to be within a 1 km range.

Since launching in June, All U Me now has 2,000 active subscribers in Copenhagen. There are plans to expand into Sweden, Germany, and the UK, but partnerships with existing jewellery brands – to integrate its safety devices into their existing designs – will be crucial for helping this technology reach more women. 

“There are so many jewelry brands in the world, I don’t want to be another one,” says Knusden. 

“We want to be a technology enabler. Our vision is to empower and inspire everyone – people, brands, organisations – to stand against harassment, whether they do it by downloading the app, or partnering with us to make the jewellery. This is how we will scale through these partnerships.”

She has big ambitions, believing All U Me could be the “first social impact unicorn”, combining scalable tech, commercial sustainability, and philanthropy. 

“I have global ambitions with this, but I also have philanthropical ambitions, in the sense that I believe that every young girl and woman should be able to feel safe and be who they are, Knusden adds. 

Sharing her experience of using All U Me, one woman described her sense of safety as going from a “two to a four out of five”. 

“Her feeling of safety doubled,” Knusden emphasises. “It’s not a 100 per cent guarantee, but it meant that she stopped carrying her keys between her fingers. If we can make people feel safer, and if we can make it easier for bystanders to act, then we can change the world.”

 

News

Bridging the metabolic wealth gap: The telehealth platform bypassing insurance to democratise care

Published

on

As weight-loss treatments remain locked behind prohibitive paywalls, a new direct-pay initiative is cutting costs in half for low-income patients, and it could provide a new blueprint for health equity.

It is one of the most persistent, frustrating paradoxes in modern healthcare: the medical innovations most capable of addressing widespread chronic conditions are overwhelmingly priced out of reach for the populations most vulnerable to them.

Nowhere is this more evident than in the current landscape of metabolic health and weight management.

As state governments and insurance providers increasingly restrict coverage for advanced weight-loss medications due to skyrocketing costs, a stark dividing line has emerged. Clinical need is no longer the primary factor in who receives treatment. Affordability is.

This financial barrier disproportionately impacts women, who not only face high rates of metabolic conditions but also frequently serve as the primary caregivers in their households.

For a single mother managing childcare, grueling work hours, and the relentlessly rising cost of living, personal well-being is often the first casualty of a tight budget.

These patients are forced into a holding pattern, watching their conditions progress year after year while highly effective, life-changing treatments remain separated from them by a paywall.

Now, a telehealth platform called Amble Health is attempting to dismantle that wall by bypassing the traditional insurance apparatus entirely.

A Structural Shift for Access

Today, Amble Health announced the launch of the Amble Cares Program, a national initiative designed to cut the cost of medical weight-loss treatments in half for low-income Americans.

The programme arrives at a critical inflection point.

Today, roughly one in eight U.S. adults have utilized advanced metabolic medications, according to a recent KFF Health Tracking Poll.

This surge in adoption has driven a fundamental shift in preventative care, but the distribution of that care has been deeply uneven.

Through the Amble Cares Program, eligible patients can access comprehensive medical weight-loss programmes, which may include prescription medications if clinically appropriate, at up to 50 per cent below standard rates.

To ensure the discounts reach the intended demographic, eligibility is determined by an independent, third-party verification partner, based on verified financial need.

The programme explicitly prioritises individuals and families with limited disposable income, including parents and guardians whose financial flexibility is tied up in providing for dependents.

Once verified, patients are connected directly to licensed clinicians to begin treatment immediately, stripping away the friction of waiting periods.

“Healthcare should not be a luxury item,” said Joey Stiver, CEO of Amble Health. At Amble, we believe that a patient’s zip code or income shouldn’t dictate their metabolic health outcomes.

“The Amble Cares Program is our direct response to the cost of living crisis, moving beyond talk of ‘affordability’ to actually delivering it to the people the traditional system has left behind.”

The Direct-Pay Trade-Off

However, this rapid, lower-cost access comes with a significant structural trade-off.

To achieve these price reductions and eliminate the administrative delays, denials, and red tape associated with traditional healthcare, Amble Health operates strictly as a direct-pay platform.

This means participants cannot use outside coverage. The programme does not accept Medicaid, Medicare, commercial insurance, or even HSA/FSA funds.

For some patients, being entirely locked out of utilizing their existing health benefits may present a new kind of hurdle.

But for those who have already found themselves abandoned by traditional coverage networks, facing outright denials, unnavigable prior authorisations, or insurmountable deductibles, the direct-pay model offers a predictable, transparent alternative to a broken system.

Ultimately, the Amble Cares Program is making a bold bet: that the most efficient way to deliver equitable healthcare to disenfranchised populations isn’t to fix the traditional insurance system, but to innovate entirely around it.

Continue Reading

News

UK report warns against ‘financial half measures’ for women’s health

Published

on

The Women and Equalities Committee (WEC) has warned against “financial half measures” on women’s health as the government published its response to the report.

Ministers launched the renewed Women’s Health Strategy in April after the committee’s March report concluded it was not convinced that the menstrual and gynaecological needs of young women and girls had been sufficiently prioritised in wider healthcare reforms.

It followed the committee’s 2024 “medical misogyny” report, which found women with painful reproductive health conditions such as endometriosis, adenomyosis and heavy menstrual bleeding were frequently finding their symptoms “normalised” and their “pain dismissed” when seeking help.

In both reports, MPs called on the government to recognise the benefits of increased investment in early diagnosis and treatment of women’s reproductive health conditions and provide additional funding needed to transform the support available to millions of women.

In its response, published on 26 May as a command paper, the Department of Health and Social Care outlined action on reducing gynae waiting times, ensuring procedures are conducted with women’s full consent and adequate pain relief, and improving access to contraception for menstrual healthcare in line with the committee’s recommendations.

It said: “The government agrees with the committee’s overarching findings and recommendations for improving women’s health outcomes and experiences.

“We acknowledge the impact that menstrual health conditions can have on women’s lives, relationships, and participation in education and the workforce.

“We recognise that more needs to be done to support women with menstrual health conditions, particularly around listening to women, improving information and education, and enhancing patient experience.”

However, there was no commitment to increase school nurse provision, no measurable actions and targets on countering online misinformation, no new commitments to end inappropriate censorship of women’s online health content, and no further initiatives on tackling racial discrimination or understanding the menstrual wellbeing needs of young disabled and Deaf women.

The response comes after analysis by The Times suggested the government is allocating 60 per cent more funding to its men’s health strategy than to its renewed strategy for women’s health.

Sarah Owen, chair of the Women and Equalities Committee and Labour MP, said: “WEC’s 2024 ‘medical misogyny’ report warned 18 months ago of women in unnecessary pain and undiagnosed for years and called on the Government to recognise the benefits of increased investment in early diagnosis and treatment.

“Our follow up report this March cautioned girls’ and women’s health are not being sufficiently prioritised in system-wide NHS reforms, while initiatives which have proven to be successful in reducing waiting lists and improving women’s healthcare access, such as women’s health hubs, risked being scaled back or discontinued.

“While it’s welcome to see a focus on tackling ‘medical misogyny’ in April’s renewed Women’s Health Strategy and an emphasis on women’s voices being heard, this must be backed by adequate funding, not financial half measures, particularly when compared to men’s health.

“Significant questions remain following today’s response publication over the adequacy of investment being provided, including for workforce training, menstrual health education in schools, research and additional ring-fenced funding for women’s health hubs to deliver services within the emerging neighbourhood health framework.

“There are both opportunities and risks when it comes to increasing use of technology in women’s healthcare.

“As the Committee’s report set out, social media companies should be held to account for inappropriate and disgraceful ‘shadow banning’ censorship of important women’s health content and there should be a rigorous approach to tackling the risks from ineffective, unsafe and exploitative for-profit FemTech apps.

“The Government should take the problem of ‘shadow banning’ more seriously.

“A strategy which does not fully address the concerns set out in WEC’s report, alongside measurable actions and timescales, will only scratch the surface of the issues facing women’s health.

“WEC will keep a close eye on progress and continue to push for long overdue tangible change for women and girls.”

Continue Reading

Cancer

Early PET scan could chemo response in aggressive breast cancer – study

Published

on

An early PET scan after one cycle of chemotherapy may help predict how aggressive breast cancer responds to treatment, a study suggests.

Research led by The Institute of Cancer Research, London and King’s College London suggests that an early scan taken after one cycle of chemotherapy could help predict how well a patient’s cancer will respond to treatment.

The study focused on patients with triple-negative breast cancer (TNBC), an aggressive form of the disease in which cancer cells lack receptors for the hormones oestrogen and progesterone, as well as the HER2 protein.

Patients with TNBC are usually treated with chemotherapy prior to surgery. While many respond well, residual disease at surgery, typically around six months later, is associated with a significantly poorer prognosis. Identifying people sooner who are unlikely to respond remains a major clinical challenge.

The research explored whether using PET imaging shortly after treatment begins, rather than relying only on MRI scans later in the treatment process, could provide earlier insight into how a patient’s cancer is responding. Twenty-two patients were recruited, with fourteen undergoing FDG-PET scans before treatment and after the first cycle of chemotherapy.

The findings, published in Clinical Cancer Research, showed that changes seen on PET scans after just one cycle of chemotherapy were strongly associated with subsequent response, including whether there was no detectable cancer, known as a complete response, by the end of treatment. Importantly, early PET response showed stronger associations with treatment outcomes than standard mid-treatment MRI scans in this study.

Being able to identify patients who are not responding well at an early stage could allow clinicians to adjust treatment sooner or consider alternative approaches. These findings may also support future strategies to better tailor treatment intensity to individual patients.

The study also compared two types of PET tracers, FDG and FLT, to determine which was most suitable. While both met the study’s technical criteria, FDG-PET was selected for further evaluation due to its better image quality, greater consistency and wider use in clinical practice.

The research also explored how imaging changes after just one cycle of chemotherapy relate to the body’s immune response to treatment. Biopsies taken before and after the first cycle of chemotherapy showed that an increase in immune cells within the tumour was strongly associated with both early PET changes and improved treatment outcomes.

The researchers emphasise that these findings now need to be validated in larger studies. Future work will aim to confirm these results in broader patient groups and explore more accessible imaging approaches, such as ultrasound, alongside PET and MRI.

Sheeba Irshad, professor of cancer immunology at King’s College London and lead of the Breast Cancer Now KCL Research Unit, said:

“In patients who had PET scans both before treatment and after the first cycle, we found that this early scan could predict whether they were likely to achieve a complete response by the end of treatment. These findings highlight the potential of early imaging to guide treatment decisions, and now need to be validated in larger, modern clinical trials.”

Andrew Tutt, professor of breast oncology at The Institute of Cancer Research, London, said:

“Research that helps us determine early who is already benefitting from standard neoadjuvant chemotherapy and who might benefit from clinical trials to find better treatments is vital. This study shows that FDG-PET may have great value in this regard. We hope to be able to design studies that further investigate and validate these findings.”

The study was supported by funding from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, Breast Cancer Now, Cancer Research UK, and Guy’s and St Thomas’ Charity.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.